Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SATISFY-JP, a phase II multicenter open-label study on Satralizumab, an anti-IL-6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune-responsive-phenotype: Study protocol.
Tamura Y, Takeyasu R, Takata T, Miyazaki N, Takemura R, Wada M, Tamura Y, Abe K, Shigeta A, Taniguchi Y, Adachi S, Inami T, Tsujino I, Tahara N, Kuwana M. Tamura Y, et al. Among authors: tahara n. Pulm Circ. 2023 Jun 19;13(2):e12251. doi: 10.1002/pul2.12251. eCollection 2023 Apr. Pulm Circ. 2023. PMID: 37342675 Free PMC article.
Selexipag for Chronic Thromboembolic Pulmonary Hypertension in Japanese Patients　- A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase II Study.
Tanabe N, Fukuda K, Matsubara H, Nakanishi N, Tahara N, Ikeda S, Kishi T, Satoh T, Hirata KI, Inoue T, Kimura H, Okano Y, Okazaki O, Sata M, Tsujino I, Ueno S, Yamada N, Yao A, Kuriyama T. Tanabe N, et al. Among authors: tahara n. Circ J. 2020 Sep 25;84(10):1866-1874. doi: 10.1253/circj.CJ-20-0438. Epub 2020 Sep 3. Circ J. 2020. PMID: 32879152 Free article. Clinical Trial.
Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial Hypertension.
Tahara N, Dobashi H, Fukuda K, Funauchi M, Hatano M, Ikeda S, Joho S, Kihara Y, Kimura T, Kondo T, Matsushita M, Minamino T, Nakanishi N, Ozaki Y, Saji T, Sakai S, Tanabe N, Watanabe H, Yamada H, Yoshioka K, Sasayama S. Tahara N, et al. Circ J. 2016 May 25;80(6):1478-83. doi: 10.1253/circj.CJ-15-1305. Epub 2016 May 13. Circ J. 2016. PMID: 27180890 Free article.
Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension.
Tanabe N, Ikeda S, Tahara N, Fukuda K, Hatano M, Ito H, Nakayama T, Anzai T, Hashimoto A, Inoue T, Kajinami K, Kihara Y, Kinoshita H, Kuwahara K, Murohara T, Okazaki O, Sakai S, Satoh T, Takeda Y, Takeishi Y, Taniguchi M, Watanabe H, Yamamoto T, Yamauchi-Takihara K, Yoshioka K, Sasayama S. Tanabe N, et al. Among authors: tahara n. Circ J. 2017 Aug 25;81(9):1360-1367. doi: 10.1253/circj.CJ-16-1348. Epub 2017 Apr 18. Circ J. 2017. PMID: 28420826 Free article. Clinical Trial.
Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients.
Tahara N, Dobashi H, Fukuda K, Funauchi M, Hatano M, Ikeda S, Joho S, Kihara Y, Kondo T, Matsushita M, Minamino T, Nakanishi N, Okano Y, Ozaki Y, Saji T, Sakai S, Tanabe N, Watanabe H, Yamada H, Yoshioka K, Hatta M, Sasayama S. Tahara N, et al. Curr Med Res Opin. 2020 Jun;36(6):921-928. doi: 10.1080/03007995.2020.1756234. Epub 2020 May 12. Curr Med Res Opin. 2020. PMID: 32298185
Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension.
Chibana H, Tahara N, Itaya N, Ishimatsu T, Sasaki M, Sasaki M, Nakayoshi T, Ohtsuka M, Yokoyama S, Sasaki KI, Ueno T, Fukumoto Y. Chibana H, et al. Among authors: tahara n. Int J Cardiol Heart Vasc. 2017 Nov 9;17:30-32. doi: 10.1016/j.ijcha.2017.09.001. eCollection 2017 Dec. Int J Cardiol Heart Vasc. 2017. PMID: 29159269 Free PMC article.
187 results